Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

I. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Kahaly, George J.

Bioassays for TSH Receptor Antibodies: Quo Vadis?

EUROPEAN THYROID JOURNAL. Bd. 4. H. 1. 2015 S. 3-5


Dittmar, M.; Reber, H.; Kahaly, G. J.

Bioimpedance phase angle indicates catabolism in Type 2 diabetes

DIABETIC MEDICINE. Bd. 32. H. 9. 2015 S. 1177-1185


Franceschini, Franco; Bartoloni-Bocci, Elena; Castaneda, Santos et al.

Clinical Follow-up Predictors of Disease Pattern Change in Anti Jo-1 Positive Antisynthetase Syndrome: Results from a Multicenter, International and Retrospective Study

ARTHRITIS & RHEUMATOLOGY. Bd. 67. 2015


Pape, U. F.; Bacher, M.; Fottner, C. et al.

Clinical Outcome of Everolimus Treatment of Advanced Neuroendocrine Neoplasms: 'Real-Life' Data from the German NET-Register

NEUROENDOCRINOLOGY. Bd. 102. H. 1-2. 2015 S. 132-132



Menke, Julia; Amann, Kerstin; Cavagna, Lorenzo et al.

Colony-Stimulating Factor-1: A Potential Biomarker for Lupus Nephritis

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. Bd. 26. H. 2. 2015 S. 379-389


Krawczyk, Marcin; Rau, Monika; Schattenberg, Joern et al.

Combined effects of the prosteatotic TM6SF2 and PNPLA3 mutations on NALFD severity: multicentre biopsy-based study

HEPATOLOGY. Bd. 62. 2015 S. 1278A-1278A



Klöckner, Roman; Weinmann, Arndt; Prinz, Friederike et al.

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

BMC cancer. Bd. 15. London: BioMed Central 2015 Art. 465


Foerster, F.; Woerns, M. A.; Galle, P. R. et al.

Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure

ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 53. H. 12. 2015 S. 1414-1421